奎孕酮
化合物
奎孕酮(英語:Quingestrone)也稱為孕酮-3-烯醇環戊醚(progesterone 3-cyclopentyl enol ether,PCPE)是一種黃體製劑藥物,在1962年起用作複合口服避孕藥,但在意大利等國已不再使用[1][2][3][4][5]
臨床資料 | |
---|---|
商品名 | Enol-Luteovis |
其他名稱 | W-3399; Progesterone 3-cyclopentyl enol ether; PCPE; 3-Cyclopentyloxypregna-3,5-dien-20-one |
給藥途徑 | By mouth |
藥物類別 | Progestin; Progestogen; Progestogen ether; Neurosteroid |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
識別資訊 | |
| |
CAS號 | 67-95-8 |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C26H38O2 |
摩爾質量 | 382.579 g/mol |
3D模型(JSmol) | |
| |
|
奎孕酮作為一種黃體製劑(人工合成的孕激素),能作為孕酮的生物學靶點——孕酮受體的激動劑[1],另外也具有較弱的糖皮質激素活性。
參考文獻
編輯- ^ 1.0 1.1 J. Elks. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014: 1058 [2019-02-26]. ISBN 978-1-4757-2085-3. OCLC 898564124. doi:10.1007/978-1-4757-2085-3. (原始內容存檔於2021-01-26).
- ^ International Planned Parenthood Federation. Medical Committee. Oral Advisory Group. Handbook on oral contraception. Little, Brown. 1965: 18 [2019-02-26]. OCLC 2717593. (原始內容存檔於2021-01-07).
- ^ Larrey D, Geneve J, Pessayre D, Machayekhi JP, Degott C, Benhamou JP. Prolonged cholestasis after cyproheptadine-induced acute hepatitis. J. Clin. Gastroenterol. 1987, 9 (1): 102–4. ISSN 0192-0790. PMID 3559100. doi:10.1097/00004836-198702000-00026.
She had been taking an oral contraceptive combining ethinylestradiol and quingestrone since 1980.
- ^ Denis Frank Hawkins. Obstetric therapeutics: clinical pharmacology and therapeutics in obstetric practice. Baillière Tindall. 1974: 129, 138, 145 [2019-02-26]. ISBN 978-0-7020-0471-1. (原始內容存檔於2020-08-19).
- ^ P. J. Bentley. Endocrine Pharmacology: Physiological Basis and Therapeutic Applications. CUP Archive. 1980: 274– [2019-02-26]. ISBN 978-0-521-22673-8. (原始內容存檔於2020-08-20).